Evidence map›Paper›PMID 37642022›Full record

Trial reportJournal of the American Heart Association2023

Long-Term Impact of Additional Ablation After Pulmonary Vein Isolation: Results From EARNEST-PVI Trial.

Masaharu Masuda, Koichi Inoue, Nobuaki Tanaka, Tetsuya Watanabe, Nobuhiko Makino, Yasuyuki Egami, Takafumi Oka, Hitoshi Minamiguchi, Miwa Miyoshi, Masato Okada and 13 more

Abstract readRandomized Controlled TrialMulticenter Study
In one paragraph

Trial report in Journal of the American Heart Association, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Automated generation of ablation lesion masks: a unison of electro and optic flow mapping for persistent AF virtual cohorts.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2026
    Article
  7. Article
  8. Persistent atrial fibrillation ablation: glimpsing the light ahead?Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors.

Masaharu MasudaCardiovascular Center Kansai Rosai Hospital Amagasaki Japan.ORCID 0000-0002-5566-466X
Koichi InoueCardiovascular Division National Hospital Organization Osaka National Hospital Osaka Japan.ORCID 0000-0002-8389-549X
Nobuaki TanakaCardiovascular Center Sakurabashi Watanabe Hospital Osaka Japan.
Tetsuya WatanabeDivision of Cardiology Osaka General Medical Center Osaka Japan.ORCID 0000-0003-3979-527X
Nobuhiko MakinoCardiovascular Division Osaka Police Hospital Osaka Japan.
Yasuyuki EgamiDivision of Cardiology Osaka Rosai Hospital Sakai Japan.ORCID 0000-0001-9728-6524
Takafumi OkaDepartment of Cardiovascular Medicine Osaka University Graduate School of Medicine Osaka Japan.
Hitoshi MinamiguchiCardiovascular Division Osaka Police Hospital Osaka Japan.
Miwa MiyoshiDepartment of Cardiology Osaka Hospital, Japan Community Healthcare Organization Osaka Japan.ORCID 0000-0003-3279-7678
Masato OkadaCardiovascular Center Sakurabashi Watanabe Hospital Osaka Japan.ORCID 0000-0002-3190-7313
Takashi KandaCardiovascular Division Osaka Police Hospital Osaka Japan.
Toshiaki ManoCardiovascular Center Kansai Rosai Hospital Amagasaki Japan.
Yasuhiro MatsudaCardiovascular Center Kansai Rosai Hospital Amagasaki Japan.
Hiroyuki UematsuCardiovascular Center Kansai Rosai Hospital Amagasaki Japan.
Takashige SakioCardiovascular Center Kansai Rosai Hospital Amagasaki Japan.
Masato KawasakiDivision of Cardiology Osaka General Medical Center Osaka Japan.
Akihiro SunagaDepartment of Cardiovascular Medicine Osaka University Graduate School of Medicine Osaka Japan.ORCID 0000-0003-2590-6696
Yohei SotomiDepartment of Cardiovascular Medicine Osaka University Graduate School of Medicine Osaka Japan.
Tomoharu DohiDepartment of Cardiovascular Medicine Osaka University Graduate School of Medicine Osaka Japan.ORCID 0000-0003-1652-6421
Daisaku NakataniDepartment of Cardiovascular Medicine Osaka University Graduate School of Medicine Osaka Japan.ORCID 0000-0002-1534-2033
Shungo HikosoDepartment of Cardiovascular Medicine Osaka University Graduate School of Medicine Osaka Japan.ORCID 0000-0003-2284-1970
Yasushi SakataDepartment of Cardiovascular Medicine Osaka University Graduate School of Medicine Osaka Japan.
Osaka Cardiovascular Conference (OCVC)‐Arrhythmia Investigators

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background An optimal strategy for left atrial ablation in addition to pulmonary vein isolation (PVI) in patients with persistent atrial fibrillation (AF) has not been determined. Methods and Results We conducted an extended follow-up of the multicenter randomized controlled EARNEST-PVI (Efficacy of Pulmonary Vein Isolation Alone in Patients With Persistent Atrial Fibrillation) trial, which compared 12-month rhythm outcomes in patients with persistent AF between patients randomized to a PVI-alone strategy (n=248) or PVI-plus strategy (n=248; PVI followed by left atrial additional ablation, including linear ablation or ablation targeting areas with complex fractionated electrograms). The present study extended the follow-up period to 3 years after enrollment. Outcomes were compared not only between randomly allocated groups but also between on-treatment groups categorized by actually created ablation lesions. Recurrence rate of AF or atrial tachycardia (AT) was lower in the randomly allocated to PVI-plus group than the PVI-alone group (29.0% versus 37.5%,

Indexed as

Atrial AppendageAtrial FibrillationAtrial FlutterPulmonary VeinsHeart AtriaHumansleft atrial ablationlinear ablationpersistent atrial fibrillationrecurrence

Identifiers

PMID37642022
PMCPMC10547359

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.